K. Un

发表

Intracellular trafficking mechanism, from intracellular uptake to extracellular efflux, for phospholipid/cholesterol liposomes.

K. Sakai-Kato, T. Kawanishi, H. Okuda, 2012, Biomaterials.

In vivo anti-tumor effect of PEG liposomal doxorubicin (DOX) in DOX-resistant tumor-bearing mice: Involvement of cytotoxic effect on vascular endothelial cells.

K. Higaki, Toshikiro Kimura, K. Ogawara, 2009, Journal of controlled release : official journal of the Controlled Release Society.

Enhanced transfection efficiency into macrophages and dendritic cells by a combination method using mannosylated lipoplexes and bubble liposomes with ultrasound exposure.

S. Kawakami, M. Hashida, F. Yamashita, 2010, Human gene therapy.

Effects of liposomal phospholipids and lipid transport-related protein on the intracellular fate of encapsulated doxorubicin.

K. Sakai-Kato, Y. Goda, T. Kawanishi, 2014, Molecular pharmaceutics.

Evaluation of inflammatory responses due to small interfering RNA transfer using unmodified- and mannose-modified bubble lipoplexes with ultrasound exposure in primary cultured macrophages

S. Kawakami, M. Hashida, F. Yamashita, 2014, Journal of drug targeting.

Sequence Requirements for a-Fetoprotein Gene Expression

Miriam, Jean, H., 2005 .

Determinants for in vivo antitumor effect of angiogenesis inhibitor SU5416 formulated in PEGylated emulsion.

K. Higaki, Toshikiro Kimura, K. Ogawara, 2014, Journal of pharmaceutical sciences.

Determinants for in vivo anti-tumor effects of PEG liposomal doxorubicin: importance of vascular permeability within tumors.

K. Higaki, Toshikiro Kimura, K. Ogawara, 2008, International journal of pharmaceutics.

Synthesis and evaluation of glyco-coated liposomes as drug carriers for active targeting in drug delivery systems.

S. Kawakami, M. Hashida, F. Yamashita, 2015, Carbohydrate research.

[Development of cell-selective gene transfection method using sugar-modified and ultrasound-responsive liposomes].

K. Un, 2012, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan.

Development of an ultrasound-responsive and mannose-modified gene carrier for DNA vaccine therapy.

S. Kawakami, M. Hashida, F. Yamashita, 2010, Biomaterials.

Suppression of melanoma growth and metastasis by DNA vaccination using an ultrasound-responsive and mannose-modified gene carrier.

Fumiyoshi Yamashita, Mitsuru Hashida, Shigeru Kawakami, 2011, Molecular pharmaceutics.

Enhancement of the anti-tumor effect of DNA vaccination using an ultrasound-responsive mannose-modified gene carrier in combination with doxorubicin-encapsulated PEGylated liposomes.

S. Kawakami, M. Hashida, F. Yamashita, 2014, International journal of pharmaceutics.

Nanoparticle-based passive drug targeting to tumors: considerations and implications for optimization.

Ken-ichi Ogawara, Kazutaka Higaki, Tomoya Araki, 2013, Biological & pharmaceutical bulletin.

Elucidating the molecular mechanism for the intracellular trafficking and fate of block copolymer micelles and their components.

H. Kusuhara, N. Nishiyama, K. Kataoka, 2014, Biomaterials.

Efficient suppression of murine intracellular adhesion molecule‐1 using ultrasound‐responsive and mannose‐modified lipoplexes inhibits acute hepatic inflammation

S. Kawakami, M. Hashida, F. Yamashita, 2012, Hepatology.

Involvement of activated transcriptional process in efficient gene transfection using unmodified and mannose-modified bubble lipoplexes with ultrasound exposure.

S. Kawakami, M. Hashida, F. Yamashita, 2011, Journal of controlled release : official journal of the Controlled Release Society.

Physicochemical properties and in vitro intestinal permeability properties and intestinal cell toxicity of silica particles, performed in simulated gastrointestinal fluids.

K. Sakai-Kato, T. Kawanishi, H. Okuda, 2014, Biochimica et biophysica acta.

Elucidating the molecular mechanism for the intracellular trafficking and fate of block copolymer micelles and their components.

H. Kusuhara, N. Nishiyama, K. Kataoka, 2014, Biomaterials.